Induction of Release of Tumor Necrosis Factor from Human Monocytes by Staphylococci and Staphylococcal Peptidoglycans

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1993 Oct 1

PMID 8406805

Citations 60

Authors

C P Timmerman

E Mattsson

L Martinez-Martinez

L de Graaf

J A Van Strijp

H A Verbrugh

J Verhoef

A Fleer

Affiliations

Soon will be listed here.

Abstract

The role of cytokines in gram-positive infections is still relatively poorly defined. The purpose of this study was to establish whether or not intact staphylococci and purified peptidoglycans and peptidoglycan components derived from staphylococci are capable of stimulating the release of tumor necrosis factor (TNF) by human monocytes. We show here that intact staphylococci and purified peptidoglycans, isolated from three Staphylococcus epidermidis and three S. aureus strains, were indeed able to induce secretion of TNF by human monocytes in a concentration-dependent fashion. TNF release was detected by both enzyme immunoassay and the L929 fibroblast bioassay. In the enzyme immunoassay, a minimal concentration of peptidoglycan of 1 micrograms/ml was required to detect TNF release by monocytes, whereas in the bioassay a peptidoglycan concentration of 10 micrograms/ml was needed to detect a similar amount of TNF release. Peptidoglycan components such as the stem peptide, tetra- and pentaglycine, and muramyl dipeptide were unable to induce TNF release from human monocytes.

Citing Articles

Anti-MRSA effects of synergism of recombinant lysostaphin with biosynthesized silver nanoparticles.

Saleh Z, Mizher B Open Vet J. 2025; 14(12):3569-3580.

PMID: 39927374 PMC: 11799647. DOI: 10.5455/OVJ.2024.v14.i12.39.

Single-cell Sequencing of Circulating Human Plasmablasts during Staphylococcus aureus Bacteremia.

Kerkman P, de Vor L, van der Vaart T, Ten Doesschate T, Muts R, Depelteau J J Immunol. 2024; 213(11):1644-1655.

PMID: 39451041 PMC: 7616744. DOI: 10.4049/jimmunol.2300858.

enhances gelatinase activities in monocytic U937 cells and in human gingival fibroblasts.

Chang Y, Chiang C, Fu E, Chiu H J Dent Sci. 2022; 17(3):1321-1328.

PMID: 35784159 PMC: 9236941. DOI: 10.1016/j.jds.2022.04.014.

Human monoclonal antibodies against surface antigens recognize in vitro and in vivo biofilm.

de Vor L, Dijk B, van Kessel K, Kavanaugh J, de Haas C, Aerts P Elife. 2022; 11.

PMID: 34989676 PMC: 8751199. DOI: 10.7554/eLife.67301.

Overview of procalcitonin in pregnancy and in pre-eclampsia.

Mangogna A, Agostinis C, Ricci G, Romano F, Bulla R Clin Exp Immunol. 2019; 198(1):37-46.

PMID: 31081935 PMC: 6718355. DOI: 10.1111/cei.13311.

References

Calandra T, Baumgartner J, Grau G, Wu M, Lambert P, Schellekens J . Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis. 1990; 161(5):982-7. DOI: 10.1093/infdis/161.5.982. View

Cannon J, Tompkins R, Gelfand J, Michie H, Stanford G, van der Meer J . Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis. 1990; 161(1):79-84. DOI: 10.1093/infdis/161.1.79. View

Wakabayashi G, Gelfand J, Jung W, Connolly R, Burke J, Dinarello C . Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. J Clin Invest. 1991; 87(6):1925-35. PMC: 296944. DOI: 10.1172/JCI115218. View

Benabdelmoumene S, Dumont S, Petit C, Poindron P, Wachsmann D, Klein J . Activation of human monocytes by Streptococcus mutans serotype f polysaccharide: immunoglobulin G Fc receptor expression and tumor necrosis factor and interleukin-1 production. Infect Immun. 1991; 59(9):3261-6. PMC: 258161. DOI: 10.1128/iai.59.9.3261-3266.1991. View

van Kessel K, Van Strijp J, Verhoef J . Inactivation of recombinant human tumor necrosis factor-alpha by proteolytic enzymes released from stimulated human neutrophils. J Immunol. 1991; 147(11):3862-8. View

Mathison J, Tobias P, Wolfson E, Ulevitch R . Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. J Immunol. 1992; 149(1):200-6. View

Vaudaux P, Grau G, Huggler E, Fiedler F, Waldvogel F, Lew D . Contribution of tumor necrosis factor to host defense against staphylococci in a guinea pig model of foreign body infections. J Infect Dis. 1992; 166(1):58-64. DOI: 10.1093/infdis/166.1.58. View

BARTLETT G . Phosphorus assay in column chromatography. J Biol Chem. 1959; 234(3):466-8. View

Adlam C, Broughton E, Scott M . Enhanced resistance of mice to infection with bacteria following pre-treatment with Corynebacterium parvum. Nat New Biol. 1972; 235(59):219-20. DOI: 10.1038/newbio235219a0. View

10.

Rotta J . Endotoxin-like properties of the peptidoglycan. Z Immunitatsforsch Exp Klin Immunol. 1975; 149(2-4):230-44. View

11.

Peterson P, Verhoef J, Sabath L, Quie P . Effect of protein A on staphylococcal opsonization. Infect Immun. 1977; 15(3):760-4. PMC: 421436. DOI: 10.1128/iai.15.3.760-764.1977. View

12.

Peterson P, Wilkinson B, Kim Y, Schmeling D, Douglas S, Quie P . The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest. 1978; 61(3):597-609. PMC: 372572. DOI: 10.1172/JCI108971. View

13.

Wilkinson B, Kim Y, Peterson P, Quie P, Michael A . Activation of complement by cell surface components of Staphylococcus aureus. Infect Immun. 1978; 20(2):388-92. PMC: 421867. DOI: 10.1128/iai.20.2.388-392.1978. View

14.

Spika J, Peterson P, Wilkinson B, Hammerschmidt D, Verbrugh H, Verhoef J . Role of peptidoglycan from Staphylococcus aureus in leukopenia, thrombocytopenia, and complement activation associated with bacteremia. J Infect Dis. 1982; 146(2):227-34. DOI: 10.1093/infdis/146.2.227. View

15.

Sheagren J . Staphylococcus aureus. The persistent pathogen (first of two parts). N Engl J Med. 1984; 310(21):1368-73. DOI: 10.1056/NEJM198405243102107. View

16.

Gold M, Miller C, Mishell R . Soluble non-cross-linked peptidoglycan polymers stimulate monocyte-macrophage inflammatory functions. Infect Immun. 1985; 49(3):731-41. PMC: 261259. DOI: 10.1128/iai.49.3.731-741.1985. View

17.

Paquet Jr A, Raines K, Brownback P . Immunopotentiating activities of cell walls, peptidoglycans, and teichoic acids from two strains of Listeria monocytogenes. Infect Immun. 1986; 54(1):170-6. PMC: 260132. DOI: 10.1128/iai.54.1.170-176.1986. View

18.

Stillman R, Wenzel R, Donowitz L . Emergence of coagulase negative staphylococci as major nosocomial bloodstream pathogens. Infect Control. 1987; 8(3):108-12. DOI: 10.1017/s0195941700067278. View

19.

Eykyn S . Staphylococcal sepsis. The changing pattern of disease and therapy. Lancet. 1988; 1(8577):100-4. DOI: 10.1016/s0140-6736(88)90294-2. View

20.

Takahashi I, Kotani S, Takada H, Shiba T, Kusumoto S . Structural requirements of endotoxic lipopolysaccharides and bacterial cell walls in induction of interleukin-1. Blood Purif. 1988; 6(3):188-206. DOI: 10.1159/000169545. View